SEQOVA Ventures

SEQOVA doesn’t just advise. We lead and structure therapeutic venture opportunities, aligning the right assets, capabilities, and partners to create durable value across borders.

From Insight to Investment: Leading the Next Wave of Therapeutic Opportunity

SEQOVA Ventures is the natural extension of our strategic expertise. Our on-the-ground experience allows us to identify high-potential therapeutic assets early and bring together the right stakeholders, guiding opportunities from concept through execution and creating sustainable, real-world impact.

Identify the Right Assets

We uncover high-potential therapeutic opportunities before they reach mainstream attention, leveraging deep market insights and our global expert network.

Structure Opportunities

We align the right partners, frameworks, and strategic pathways. Whether through collaboration, licensing, co-development, or investment, to maximize value and accelerate progress.

Guide to Execution

Through hands-on oversight and operational expertise, we support opportunities from early alignment through downstream execution, ensuring initiatives are strategically managed from concept to impact.

Our Approach

Selective Focus

We engage where science, strategy, and execution readiness align.

Partnership First

Collaboration is central to our model. We connect assets with the right partners across regions, disciplines, and development stages, to scale impact responsibly.

Long-Term Vision

Our goal is sustainable value creation, built on strong foundations rather than short-term transactions.

Unlocking Underutilized Assets Into Global Opportunities

SEQOVA Ventures uncovers high-potential therapeutic assets and collaboration opportunities that others overlook. On an ongoing basis, we evaluate scientific merit, regulatory positioning, and strategic fit across regions.

This includes facilitating cross-border collaborations in complex areas such as rare diseases, where aligning science, patient access, regulatory pathways, and local ecosystems is critical to meaningful progress.

For innovators in Asia, this may translate into structured collaborations or licensing pathways with EU or US partners. For EU and US stakeholders, it may strengthen pipelines, enhance long-term value, or enable access to differentiated science and patient populations. Our cross-border approach bridges regions, aligning the right assets and partners to create clear, executable pathways forward.

Creating the Next Generation of Therapeutic Venture Opportunities

At SEQOVA Ventures, we transform under-the-radar opportunities into actionable, well-structured initiatives. Leveraging SEQOVA’s network, technical depth, and structuring expertise, we enable collaborations and ventures that are often missed by traditional models.

How We Drive Value

Strategic Evaluation: Rigorous scientific, regulatory, and commercial assessment before engagement.

Creative Capital Solutions: From licensing and co-development to creative capital and strategic partnerships, we tailor structures to the needs of the asset and the partners involved.

Aligned Incentives: We commit our time and expertise upfront, remaining closely aligned with long-term outcomes rather than transactional success.

Long-Acting Injectable (LAI) Program
Among the opportunities SEQOVA Ventures is advancing is an LAI program designed as a 505(b)(2) asset with freedom-to-operate. It improves on existing CNS therapies, offering differentiation, scalability, and a clear path to value creation.
Example Opportunity

Partner with SEQOVA Ventures

Opportunities with SEQOVA Ventures represent a structured path to strategic growth. Whether you are seeking to collaborate, license, co-develop, or invest, we bring the experience, network, and execution focus needed to turn potential into lasting value.